FDA Approves Amgen's AMJEVITA AdalimumabAtto For Treatment Of Seven Inflammatory Diseases

THOUSAND OAKS Calif. Sept. 23 2016 PRNewswire &160;Amgen NASDAQAMGN today announced that the U.S. Food and Drug Administration FDA has approved AMJEVITA&8482; adalimumabatto across all eligible indications of the reference product Humira&174; a...